Abi-mediated suppression of mitochondrial respiration and CDK1-mediated pathways, coupled with Prog-mediated inhibition of glucose metabolism via CDK1 modulation, presents a multifaceted approach to combat GBM malignancy. Here, CDK1 is linked to glioblastoma.